Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03112720 · ClinicalTrials.gov registry record · Phase 3
Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache
A Phase 3 study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- Phase 3
- Development phase
- 8
- Enrollment target
NCT03112720 is a Phase 3 study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 8 participants.
The verdict
NCT03112720, a Phase 3 study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to compare a pain block in the midface, versus the traditional, more invasive, therapeutic epidural patch for the treatment of headaches
Interventions
- DEVICE Epidural Blood Patch
- DRUG Sphenopalatine Ganglion Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-09 |
| Est. Completion | 2020-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03112720
The ClinicalTrials.gov registry entry for NCT03112720 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Epidural Blood Patch is the first listed.
NCT03112720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03112720 about?
NCT03112720 is a clinical study titled "Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache". The purpose of this study is to compare a pain block in the midface, versus the traditional, more invasive, therapeutic epidural patch for the treatment of headaches
What is the current status of trial NCT03112720?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 8 participants. The study started on 2016-09. Estimated completion is 2020-09.
What interventions are being tested in trial NCT03112720?
The interventions under investigation include: Epidural Blood Patch (DEVICE), Sphenopalatine Ganglion Block (DRUG).
Who is sponsoring clinical trial NCT03112720?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.